Zepp Total Revenue vs Research Development Analysis

ZEPP Stock

USD 2.48 0.02 0.80%

Zepp Health financial indicator trend analysis is more than just analyzing Zepp Health Corp current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zepp Health Corp is a good investment. Please check the relationship between Zepp Health Total Revenue and its Research Development accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zepp Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Total Revenue vs Research Development

Total Revenue vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zepp Health Corp Total Revenue account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Zepp Health's Total Revenue and Research Development is 0.94. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Research Development in the same time period over historical financial statements of Zepp Health Corp, assuming nothing else is changed. The correlation between historical values of Zepp Health's Total Revenue and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Zepp Health Corp are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Total Revenue i.e., Zepp Health's Total Revenue and Research Development go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Revenue

Total revenue comprises all receipts Zepp Health Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Research Development

Most indicators from Zepp Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zepp Health Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zepp Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

As of 11/25/2024, Selling General Administrative is likely to grow to about 207.1 M, though Tax Provision is likely to grow to (15 M).

	2021	2022	2023	2024 (projected)
Gross Profit	1.3B	803.1M	657.8M	903.0M
Total Revenue	6.3B	4.1B	2.5B	4.1B

Gross Profit Total Revenue

Zepp Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Property Plant And Equipment Gross
Total Assets		0.75	0.86	0.97	0.8	0.62	0.96	0.3	-0.4	0.86	0.43	0.92	0.6	-0.01	0.81	0.8	0.73	0.39	0.61	0.65	0.89	0.69	0.56	0.99	0.38	0.7
Short Long Term Debt Total	0.75		0.67	0.58	0.68	0.58	0.74	0.08	0.29	0.72	-0.11	0.45	0.79	-0.44	0.43	0.38	0.59	0.17	0.89	0.54	0.77	0.82	0.22	0.72	0.67	0.62
Other Current Liab	0.86	0.67		0.85	0.7	0.54	0.94	0.21	-0.37	0.79	0.03	0.83	0.53	0.07	0.76	0.6	0.6	0.31	0.57	0.54	0.84	0.69	0.54	0.87	0.33	0.73
Total Current Liabilities	0.97	0.58	0.85		0.72	0.53	0.94	0.37	-0.59	0.79	0.54	0.96	0.44	0.15	0.83	0.84	0.66	0.45	0.46	0.57	0.82	0.54	0.57	0.98	0.21	0.64
Total Stockholder Equity	0.8	0.68	0.7	0.72		0.96	0.79	-0.31	-0.23	0.98	0.23	0.71	0.88	-0.47	0.89	0.79	0.98	-0.22	0.37	0.96	0.95	0.85	0.84	0.72	0.78	0.93
Net Tangible Assets	0.62	0.58	0.54	0.53	0.96		0.62	-0.55	-0.11	0.92	0.11	0.53	0.88	-0.64	0.82	0.72	0.93	-0.47	0.24	0.99	0.88	0.81	0.82	0.52	0.88	0.91
Property Plant And Equipment Net	0.96	0.74	0.94	0.94	0.79	0.62		0.24	-0.38	0.86	0.26	0.89	0.6	0.0	0.8	0.76	0.69	0.35	0.62	0.62	0.91	0.72	0.57	0.97	0.4	0.77
Current Deferred Revenue	0.3	0.08	0.21	0.37	-0.31	-0.55	0.24		-0.3	-0.23	0.36	0.33	-0.46	0.75	-0.13	-0.03	-0.35	0.99	0.32	-0.5	-0.15	-0.3	-0.41	0.4	-0.67	-0.41
Net Debt	-0.4	0.29	-0.37	-0.59	-0.23	-0.11	-0.38	-0.3		-0.25	-0.65	-0.72	0.23	-0.57	-0.62	-0.56	-0.27	-0.3	0.38	-0.21	-0.23	0.13	-0.55	-0.41	0.37	-0.17
Retained Earnings	0.86	0.72	0.79	0.79	0.98	0.92	0.86	-0.23	-0.25		0.21	0.76	0.85	-0.39	0.89	0.81	0.93	-0.12	0.47	0.92	0.99	0.88	0.79	0.79	0.75	0.94
Accounts Payable	0.43	-0.11	0.03	0.54	0.23	0.11	0.26	0.36	-0.65	0.21		0.53	-0.1	0.29	0.39	0.66	0.26	0.35	-0.16	0.19	0.19	-0.14	0.28	0.43	-0.22	0.03
Cash	0.92	0.45	0.83	0.96	0.71	0.53	0.89	0.33	-0.72	0.76	0.53		0.36	0.21	0.89	0.8	0.68	0.4	0.29	0.59	0.77	0.47	0.67	0.9	0.14	0.61
Non Current Assets Total	0.6	0.79	0.53	0.44	0.88	0.88	0.6	-0.46	0.23	0.85	-0.1	0.36		-0.71	0.57	0.48	0.85	-0.36	0.55	0.83	0.82	0.93	0.6	0.51	0.93	0.88
Other Assets	-0.01	-0.44	0.07	0.15	-0.47	-0.64	0.0	0.75	-0.57	-0.39	0.29	0.21	-0.71		-0.13	-0.12	-0.48	0.72	-0.14	-0.58	-0.35	-0.46	-0.23	0.1	-0.83	-0.46
Cash And Short Term Investments	0.81	0.43	0.76	0.83	0.89	0.82	0.8	-0.13	-0.62	0.89	0.39	0.89	0.57	-0.13		0.87	0.86	-0.06	0.13	0.86	0.88	0.62	0.88	0.75	0.46	0.81
Net Receivables	0.8	0.38	0.6	0.84	0.79	0.72	0.76	-0.03	-0.56	0.81	0.66	0.8	0.48	-0.12	0.87		0.72	0.03	0.16	0.75	0.81	0.49	0.69	0.77	0.4	0.69
Common Stock Total Equity	0.73	0.59	0.6	0.66	0.98	0.93	0.69	-0.35	-0.27	0.93	0.26	0.68	0.85	-0.48	0.86	0.72		-0.27	0.25	0.95	0.87	0.78	0.88	0.63	0.73	0.89
Common Stock Shares Outstanding	0.39	0.17	0.31	0.45	-0.22	-0.47	0.35	0.99	-0.3	-0.12	0.35	0.4	-0.36	0.72	-0.06	0.03	-0.27		0.42	-0.43	-0.05	-0.19	-0.34	0.49	-0.59	-0.3
Non Current Liabilities Total	0.61	0.89	0.57	0.46	0.37	0.24	0.62	0.32	0.38	0.47	-0.16	0.29	0.55	-0.14	0.13	0.16	0.25	0.42		0.18	0.53	0.68	-0.09	0.64	0.42	0.36
Capital Surpluse	0.65	0.54	0.54	0.57	0.96	0.99	0.62	-0.5	-0.21	0.92	0.19	0.59	0.83	-0.58	0.86	0.75	0.95	-0.43	0.18		0.87	0.77	0.85	0.53	0.82	0.87
Inventory	0.89	0.77	0.84	0.82	0.95	0.88	0.91	-0.15	-0.23	0.99	0.19	0.77	0.82	-0.35	0.88	0.81	0.87	-0.05	0.53	0.87		0.87	0.72	0.84	0.71	0.91
Other Current Assets	0.69	0.82	0.69	0.54	0.85	0.81	0.72	-0.3	0.13	0.88	-0.14	0.47	0.93	-0.46	0.62	0.49	0.78	-0.19	0.68	0.77	0.87		0.57	0.63	0.85	0.85
Other Stockholder Equity	0.56	0.22	0.54	0.57	0.84	0.82	0.57	-0.41	-0.55	0.79	0.28	0.67	0.6	-0.23	0.88	0.69	0.88	-0.34	-0.09	0.85	0.72	0.57		0.47	0.51	0.82
Total Liab	0.99	0.72	0.87	0.98	0.72	0.52	0.97	0.4	-0.41	0.79	0.43	0.9	0.51	0.1	0.75	0.77	0.63	0.49	0.64	0.53	0.84	0.63	0.47		0.28	0.64
Long Term Investments	0.38	0.67	0.33	0.21	0.78	0.88	0.4	-0.67	0.37	0.75	-0.22	0.14	0.93	-0.83	0.46	0.4	0.73	-0.59	0.42	0.82	0.71	0.85	0.51	0.28		0.77
Property Plant And Equipment Gross	0.7	0.62	0.73	0.64	0.93	0.91	0.77	-0.41	-0.17	0.94	0.03	0.61	0.88	-0.46	0.81	0.69	0.89	-0.3	0.36	0.87	0.91	0.85	0.82	0.64	0.77

Click cells to compare fundamentals

Zepp Health Account Relationship Matchups

Zepp Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.2B	5.9B	6.1B	5.3B	636.5M	604.7M
Short Long Term Debt Total	111.3M	680.9M	1.3B	1.7B	196.1M	186.3M
Other Current Liab	402.1M	1.9B	1.4B	638.2M	69.2M	65.8M
Total Current Liabilities	2.5B	2.8B	2.2B	1.7B	155.4M	147.6M
Total Stockholder Equity	2.5B	2.7B	2.9B	2.7B	2.5B	1.9B
Other Liab	61.2M	119.0M	207.5M	202.0M	232.3M	243.9M
Net Tangible Assets	1.7B	2.4B	2.5B	2.7B	3.1B	3.3B
Property Plant And Equipment Net	173.0M	275.8M	242.3M	166.2M	15.8M	15.0M
Current Deferred Revenue	44.8M	42.5M	4.2M	2.1M	(922.3M)	(876.2M)
Net Debt	(1.7B)	(1.6B)	(208.7M)	797.7M	62.2M	65.3M
Retained Earnings	910.6M	1.1B	1.3B	942.8M	730.7M	675.6M
Accounts Payable	2.0B	298.7M	206.7M	464.3M	44.5M	42.2M
Cash	1.8B	2.3B	1.5B	886.6M	133.9M	127.2M
Non Current Assets Total	782.3M	1.1B	2.2B	2.3B	2.3B	1.1B
Non Currrent Assets Other	8.8M	28.2M	19.6M	56.7M	2.0B	2.1B
Other Assets	111.5M	148.4M	19.6M	(3.9B)	(3.5B)	(3.3B)
Cash And Short Term Investments	1.8B	2.3B	1.5B	920.9M	985.6M	1.2B
Net Receivables	1.6B	1.2B	825.8M	802.4M	466.5M	842.3M
Common Stock Shares Outstanding	64.0M	65.1M	66.1M	61.6M	15.2M	14.4M
Short Term Investments	17.2M	23.4M	24.4M	34.3M	36.6M	37.4M
Liabilities And Stockholders Equity	5.2B	5.9B	6.1B	5.3B	636.5M	604.7M
Non Current Liabilities Total	195.4M	383.8M	999.9M	914.1M	127.9M	121.5M
Capital Lease Obligations	109.2M	116.2M	71.1M	31.7M	50.2M	46.2M
Inventory	893.8M	1.2B	1.2B	1.0B	602.7M	733.6M
Other Current Assets	67.4M	157.8M	363.0M	213.3M	193.9M	136.3M
Other Stockholder Equity	1.5B	1.6B	1.1B	144.7M	1.7B	848.5M
Total Liab	2.7B	3.2B	3.2B	2.6B	283.2M	269.1M
Long Term Investments	406.1M	444.0M	1.6B	1.7B	1.7B	1.8B
Property Plant And Equipment Gross	173.0M	275.8M	242.3M	166.2M	260.8M	146.7M
Short Long Term Debt	2.2M	504.7M	461.8M	968.4M	487.6M	307.0M
Total Current Assets	4.4B	4.8B	3.9B	3.0B	2.2B	2.9B
Accumulated Other Comprehensive Income	111.1M	44.6M	29.3M	105.8M	96.3M	64.0M
Non Current Liabilities Other	113.6M	185.2M	175.1M	162.6M	1.9M	1.8M
Short Term Debt	35.0M	512.0M	511.9M	554.3M	15.9M	15.1M
Intangible Assets	85.8M	145.2M	135.6M	123.3M	70.1M	77.0M
Common Stock	155K	157K	159K	162K	164K	136.4K

Pair Trading with Zepp Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zepp Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zepp Health will appreciate offsetting losses from the drop in the long position's value.

Moving against Zepp Stock

0.72	ASAN	Asana Inc Sell-off Trend	Pair Corr
0.49	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.48	EHGO	Eshallgo Class A	Pair Corr
0.38	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.34	CWAN	Clearwater Analytics	Pair Corr

The ability to find closely correlated positions to Zepp Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zepp Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zepp Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zepp Health Corp to buy it.

The correlation of Zepp Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zepp Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zepp Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Zepp Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Zepp Stock Analysis

When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC